BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11272165)

  • 1. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta.
    Shih DQ; Heimesaat M; Kuwajima S; Stein R; Wright CV; Stoffel M
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3818-23. PubMed ID: 11904435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
    Triggs-Raine BL; Kirkpatrick RD; Kelly SL; Norquay LD; Cattini PA; Yamagata K; Hanley AJ; Zinman B; Harris SB; Barrett PH; Hegele RA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4614-9. PubMed ID: 11904371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evolving spectrum of diabetes in a woman with GCK-MODY.
    Garrahy A; Mijares Zamuner MB; Byrne MM
    Endocrinol Diabetes Metab Case Rep; 2019 Jan; 2019():. PubMed ID: 30608898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.
    Challis BG; Harris J; Sleigh A; Isaac I; Orme SM; Seevaratnam N; Dhatariya K; Simpson HL; Semple RK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):855-61. PubMed ID: 24890200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young.
    Wang T; Zhu M; Wang Y; Hu C; Fang C; Hu J
    Endocrine; 2024 Jan; 83(1):92-98. PubMed ID: 37847371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?
    Lucchesi D; Randazzo E; Del Prato S; Bianchi C
    Acta Diabetol; 2024 Jan; 61(1):131-134. PubMed ID: 37730861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.
    Ellard S; Bellanné-Chantelot C; Hattersley AT;
    Diabetologia; 2008 Apr; 51(4):546-53. PubMed ID: 18297260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased insulin sensitivity in mice lacking collectrin, a downstream target of HNF-1alpha.
    Malakauskas SM; Kourany WM; Zhang XY; Lu D; Stevens RD; Koves TR; Hohmeier HE; Muoio DM; Newgard CB; Le TH
    Mol Endocrinol; 2009 Jun; 23(6):881-92. PubMed ID: 19246514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'I don't feel like a diabetic any more': the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing.
    Shepherd M; Hattersley AT
    Clin Med (Lond); 2004; 4(2):144-7. PubMed ID: 15139733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.
    Demiral M; Çelebi HBG; Cander S; Yerci O; Eren E; Demirbilek H
    Acta Endocrinol (Buchar); 2022; 18(4):458-465. PubMed ID: 37152879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
    Li C; Juliana CA; Yuan Y; Li M; Lu M; Chen P; Boodhansingh KE; Doliba NM; Bhatti TR; Adzick NS; Stanley CA; De León DD
    Diabetes; 2023 Dec; 72(12):1809-1819. PubMed ID: 37725835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucokinase is required for high-starch diet-induced β-cell mass expansion in mice.
    Tsuchida K; Nakamura A; Miyoshi H; Yang K; Yamauchi Y; Kawata S; Omori K; Takahashi K; Kitao N; Nomoto H; Kameda H; Cho KY; Seino Y; Terauchi Y; Atsumi T
    J Diabetes Investig; 2021 Sep; 12(9):1545-1554. PubMed ID: 33638884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment.
    Urakami T
    Diabetes Metab Syndr Obes; 2019; 12():1047-1056. PubMed ID: 31360071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators.
    Fenner D; Odili S; Hong HK; Kobayashi Y; Kohsaka A; Siepka SM; Vitaterna MH; Chen P; Zelent B; Grimsby J; Takahashi JS; Matschinsky FM; Bass J
    J Biol Chem; 2011 Nov; 286(45):39560-72. PubMed ID: 21921030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of proteomics and metabolomics reveals energy and metabolic alterations induced by glucokinase (GCK) partial inactivation in hepatocytes.
    Xie Z; Liu J; Xie T; Liu P; Hui X; Zhang Q; Xiao X
    Cell Signal; 2024 Feb; 114():111009. PubMed ID: 38092300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy.
    Capuano M; Garcia-Herrero CM; Tinto N; Carluccio C; Capobianco V; Coto I; Cola A; Iafusco D; Franzese A; Zagari A; Navas MA; Sacchetti L
    PLoS One; 2012; 7(6):e38906. PubMed ID: 22761713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.